{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T15:52:27Z","timestamp":1672329147901},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T00:00:00Z","timestamp":1553299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1093\/cvr\/cvz071","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T20:22:15Z","timestamp":1553113335000},"page":"1260-1261","source":"Crossref","is-referenced-by-count":2,"title":["Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension"],"prefix":"10.1093","volume":"115","author":[{"given":"Daphne","family":"Merkus","sequence":"first","affiliation":[{"name":"Division of Experimental Cardiology, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, CA Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleen M M","family":"van Beusekom","sequence":"additional","affiliation":[{"name":"Division of Experimental Cardiology, Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, CA Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin A","family":"Boomars","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,23]]},"reference":[{"key":"2019062109411422900_cvz071-B1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"2019062109411422900_cvz071-B2","doi-asserted-by":"crossref","first-page":"204589401880768.","DOI":"10.1177\/2045894018807681","article-title":"Are anticoagulants still indicated in pulmonary arterial hypertension?","volume":"8","author":"Olschewski","year":"2018","journal-title":"Pulm Circ"},{"key":"2019062109411422900_cvz071-B3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.drudis.2014.04.001","article-title":"Thrombosis, platelets, microparticles and PAH: more than a clot","volume":"19","author":"Lannan","year":"2014","journal-title":"Drug Discov Today"},{"key":"2019062109411422900_cvz071-B4","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.2174\/138161282130151007144725","article-title":"Therapeutic potential of targeting protease activated receptors in cardiovascular diseases","volume":"21","author":"Bulani","year":"2015","journal-title":"Curr Pharm Des"},{"key":"2019062109411422900_cvz071-B5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/cvr\/cvy284","article-title":"Proteinase-activated receptor 1 antagonism ameliorates experimental pulmonary hypertension","volume":"115","author":"Kuwabara","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2019062109411422900_cvz071-B6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1164\/rccm.201002-0255OC","article-title":"Involvement of reactive oxygen species in thrombin-induced pulmonary vasoconstriction","volume":"182","author":"Maki","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2019062109411422900_cvz071-B7","doi-asserted-by":"crossref","first-page":"L706","DOI":"10.1152\/ajplung.90598.2008","article-title":"Thrombin induces fibronectin-specific migration of pulmonary microvascular endothelial cells: requirement of calcium\/calmodulin-dependent protein kinase II","volume":"297","author":"Meoli","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2019062109411422900_cvz071-B8","doi-asserted-by":"crossref","first-page":"e00190.","DOI":"10.1002\/phy2.190","article-title":"Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension","volume":"1","author":"Ogawa","year":"2013","journal-title":"Physiol Rep"},{"key":"2019062109411422900_cvz071-B9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1513\/pats.201201-006AW","article-title":"Coagulation cascade proteinases in lung injury and fibrosis","volume":"9","author":"Chambers","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"2019062109411422900_cvz071-B10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jvs.2018.05.220","article-title":"Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes","volume":"69","author":"Posthuma","year":"2019","journal-title":"J Vasc Surg"},{"key":"2019062109411422900_cvz071-B11","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1111\/bph.12794","article-title":"PAR1-dependent COX-2\/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes","volume":"171","author":"Chien","year":"2014","journal-title":"Br J Pharmacol"},{"key":"2019062109411422900_cvz071-B12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1254\/jphs.10197FP","article-title":"Involvement of protein kinase C and RhoA in protease-activated receptor 1-mediated F-actin reorganization and cell growth in rat cardiomyocytes","volume":"115","author":"Otani","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"2019062109411422900_cvz071-B13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-018-3394-9","article-title":"Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study","volume":"451","author":"Bulani","year":"2019","journal-title":"Mol Cell Biochem"},{"key":"2019062109411422900_cvz071-B14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jacbts.2016.05.002","article-title":"Direct thrombin inhibitors prevent left atrial remodeling associated with heart failure in rats","volume":"1","author":"Jumeau","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2019062109411422900_cvz071-B15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1074248413485434","article-title":"Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts","volume":"18","author":"Sonin","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/115\/8\/1260\/28852668\/cvz071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T23:59:58Z","timestamp":1574380798000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/115\/8\/1260\/5418539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,23]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,3,23]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvz071","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7,1]]},"published":{"date-parts":[[2019,3,23]]}}}